Investigation of pulmonary inflammatory responses following intratracheal instillation of and inhalation exposure to polypropylene microplasticsResearch Published on 2024-08-062024-09-05 Journal: Particle and Fibre Toxicology [Category] update2024, [키워드] inhalation exposure intratracheal instillation microplastics Polypropylene pulmonary toxicity RAT [DOI] 10.1186/s12989-024-00592-8 PMC 바로가기 [Article Type] Research
mTOR-Inhibition and COVID-19 in Kidney Transplant Recipients: Focus on Pulmonary FibrosisPharmacology Published on 2021-08-232022-10-31 Journal: Frontiers in Pharmacology [Category] COVID-19, [키워드] Allograft antiviral properties cardiovascular disease Comorbidity COVID-19 diabetes drugs evaluated Everolimus focus high risk Immunosuppression Interaction kidney transplant recipient Kidney transplantation mitigate mTOR-inhibitors Patient pharmacological progression proliferation pulmonary pulmonary fibrosis pulmonary toxicity recipient reduce reduction risk SARS-CoV-2 SARS-CoV-2 infected patient severe COVID-19 severe disease Sirolimus T lymphocyte the cytokine storm therapeutic potential therapeutic strategy Transplant Treg with COVID-19 [DOI] 10.3389/fphar.2021.710543 PMC 바로가기 [Article Type] Pharmacology
Effectively Conducting Oncology Clinical Trials During the COVID-19 PandemicShort communication Published on 2021-05-012022-10-05 Journal: Advances in Radiation Oncology [Category] 임상, [키워드] adaptive approach Cancer clinical clinical trial Conducting coronavirus disease COVID-19 COVID-19 pandemic Critical Decline declined Enrollment help initial maintain material Multicenter trial oncology pandemic Patient pulmonary toxicity Radiation ranged Research Result risk Therapeutic benefit Trial [DOI] 10.1016/j.adro.2021.100676 [Article Type] Short communication
Upregulation of CCR4 in activated CD8 + T cells indicates enhanced lung homing in patients with severe acute SARS‐CoV‐2 infection활성화된 CD8 + T 세포에서 CCR4의 상향 조절은 중증 급성 SARS-CoV-2 감염 환자에서 향상된 폐 귀환을 나타냅니다Clinical Trial Published on 2021-04-192022-08-13 Journal: European Journal of Immunology [Category] MERS, SARS, 임상, 진단, [키워드] activated Activation affected antibody antibody secreting cell antibody secreting cells bilateral pneumonia CCR4 CD4 CD4 and CD8 T cells CD8 CD8 T cell CD8 T cells Chemokine receptor chemokine receptor CCR4 contribute COVID‐19 COVID‐19 patient COVID‐19 patients COVID‐19 differentiation disease effective effector cell expressed healthy donor healthy donors helper cells homing homing receptors hyperinflammation Hypothesis immune activation immune system immunological change immunological changes immunological phenotype independent independent of indicate lung Lung homing lung trafficking Lungs majority Mild NK‐/B‐cell Pathogenesis Patient Phenotypes Pneumonia proliferation promote pulmonary complication pulmonary complications pulmonary symptom pulmonary symptoms pulmonary toxicity raise receptor Respiratory failure responses SARS‐CoV‐2 infection SARS‐CoV2 infection SARS‐CoV‐2 severity significantly T cell T cells T‐cell T‐cell activation T‐cell exhaustion T‐follicular helper cell T‐follicular helper cells T‐cell activation therapeutic agents upregulation [DOI] 10.1002/eji.202049135 PMC 바로가기 [Article Type] Clinical Trial
A nontrivial differential diagnosis in COVID-19 pandemic: a case report and literary review of amiodarone induced interstitial pneumoniaCase Report Published on 2020-12-172022-10-31 Journal: Future Cardiology [Category] COVID-19, MERS, SARS, [키워드] Abstract adverse effects alteration Amiodarone cardiac arrhythmias Case report Computed tomography coronavirus coronavirus disease COVID-19 Diagnosis differential diagnosis drug toxicity dry cough effective etiology excluded Final interstitial pneumonia lung Lungs Nasopharyngeal swab Organizing pneumonia pandemic Patient patients Pneumonia Prevent pulmonary toxicity repeated Respiratory failure respiratory symptoms serological test Shortness of breath Side effect Side effects tested the patient therapy Toxicity treat virus was determined [DOI] 10.2217/fca-2020-0168 PMC 바로가기 [Article Type] Case Report
Severe delayed pulmonary toxicity following PD‐L1–specific CAR‐T cell therapy for non‐small cell lung cancerCase Reports Published on 2020-10-092024-09-04 Journal: Clinical & Translational Immunology [Category] 대상포진, [키워드] CAR‐T IL‐6 NSCLC PD‐L1 pulmonary toxicity [DOI] 10.1002/cti2.1154 PMC 바로가기 [Article Type] Case Reports